Search for: "BIOGEN INC." Results 101 - 120 of 259
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Apr 2007, 1:18 am
According to the settlement, the case has been dismissed.Genzyme and Biogen Idec Inc. settled another IP lawsuit in August 2005 with Columbia University, over patents that had raised over $600 million in royalties for the university. [read post]
3 Oct 2022, 8:27 am by Dennis Crouch
Kronos Incorporated, No. 22-133 Biogen International GmbH, et al. v. [read post]
8 Oct 2010, 6:58 am by Brian Dolan
In August, Biogen Idec and Knopp Neurosciences entered into an exclusive, worldwide license agreement under which Biogen Idec will develop and commercialize the drug. [read post]
23 Jun 2009, 7:15 am
Biogen Idec Inc., the maker of Tysabri, reported the case on Friday, one week after the eighth case was reported. [read post]
2 Jan 2020, 9:25 am by Beth Mole
Data examined by healthcare research firm 3 Axis Advisors found that major drug makers including Pfizer Inc, GlaxoSmithKline PLC, and Sanofi SA, Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked prices this week. [read post]
21 Jun 2017, 2:34 pm by Lawrence B. Ebert
Nov. 16, 2016), based onthis court’s ruling in Biogen MA, Inc. v. [read post]
1 Jul 2022, 10:02 am by Dennis Crouch
 Biogen International GmbH, et al. v. [read post]
7 Oct 2010, 1:50 pm by Brian Dolan
The firm was fortunate to be IP counsel for Knopp in the recently publicized Knopp – Biogen Idec transaction. [read post]
14 Dec 2015, 9:43 am by Dennis Crouch
The Ohio Willow Wood Company, No. 15-567 (If patent ownership is fixed after the filing of a complaint, can jurisdiction be cured by a supplemental complaint) Preclusion or Jurisdiction: Biogen MA, Inc. v. [read post]
6 Apr 2009, 8:20 am
., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]